{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:40:25Z","timestamp":1786995625193,"version":"build-2736575974"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1016\/j.phrs.2012.03.012","type":"journal-article","created":{"date-parts":[[2012,3,27]],"date-time":"2012-03-27T23:36:32Z","timestamp":1332891392000},"page":"80-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility"],"prefix":"10.1016","volume":"66","author":[{"given":"Caterina","family":"Lacava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Michalek-Sauberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Sgaragli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"H\u00f6ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Georg","family":"Kress","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Fusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas G.","family":"Weigl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2012.03.012_bib0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bcp.2004.10.013","article-title":"3,5-Di-t-butylcatechol (DTCAT) as an activator of rat skeletal muscle ryanodine receptor Ca2+ channel (RyRC)","volume":"69","author":"Fusi","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.phrs.2012.03.012_bib0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1750-1172-2-21","article-title":"Malignant hyperthermia","volume":"2","author":"Rosenberg","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.phrs.2012.03.012_bib0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/bja\/88.4.508","article-title":"Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees","volume":"88","author":"Davis","year":"2002","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.phrs.2012.03.012_bib0020","first-page":"A648","article-title":"A novel ryanodine receptor (RYR1) variant in two children with fatal spontaneous MH like events","volume":"109","author":"Muldoon","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2012.03.012_bib0025","series-title":"Malignant Hyperthermia","first-page":"156","article-title":"Pharmacology of volatile anaesthetics in malignant hyperthermia","author":"Weigl","year":"2000"},{"key":"10.1016\/j.phrs.2012.03.012_bib0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for the diagnosis of malignant hyperthermia following the protocol of the European MH group: results of testing patients surviving fulminant MH and unrelated low-risk subjects","volume":"41","author":"\u00d8rding","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1016\/j.phrs.2012.03.012_bib0035","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardisation of the caffeine halothane muscle contracture test","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"10.1016\/j.phrs.2012.03.012_bib0040","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00003643-200307000-00003","article-title":"Multicentre evaluation of in vitro contracture testing with bolus administration of 4-chloro-m-cresol for diagnosis of malignant hyperthermia susceptibility","volume":"20","author":"Wappler","year":"2003","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.phrs.2012.03.012_bib0045","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1017\/S0265021506000858","article-title":"Follow-up of patients tested for malignant hyperthermia susceptibility","volume":"23","author":"Scala","year":"2006","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.phrs.2012.03.012_bib0050","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1469-7793.2000.t01-1-00461.x","article-title":"Dihydropyridine induced Ca2+ release from ryanodine-receptor sensitive Ca2+ pools in human skeletal muscle cells","volume":"525","author":"Weigl","year":"2000","journal-title":"J Physiol"},{"key":"10.1016\/j.phrs.2012.03.012_bib0055","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.phrs.2012.03.012_bib0060","series-title":"Cellular calcium: a practical approach","first-page":"1","article-title":"The use of fluorescent indicators for measurements of cytosolic free calcium concentration in cell populations and single cells","author":"Thomas","year":"1991"},{"key":"10.1016\/j.phrs.2012.03.012_bib0065","first-page":"149","article-title":"Classification of malignant hyperthermia-equivocal patients by 4-chloro-m-cresol","volume":"85","author":"Gilly","year":"1997","journal-title":"Anesth Analg"},{"key":"10.1016\/j.phrs.2012.03.012_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0143-4160(88)90032-2","article-title":"Ryanodine sensitivity of the calcium release channel of sarcoplasmic reticulum","volume":"9","author":"Nagasaki","year":"1988","journal-title":"Cell Calcium"},{"key":"10.1016\/j.phrs.2012.03.012_bib0075","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1124\/mol.107.043299","article-title":"Enhanced excitation-coupled calcium entry in myotubes expressing malignant hyperthermia mutation R163C is attenuated by dantrolene","volume":"73","author":"Cherednichenko","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.phrs.2012.03.012_bib0080","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/ALN.0b013e318182a93b","article-title":"Novel ryanodine receptor mutation that may cause malignant hyperthermia","volume":"109","author":"Kaufmann","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.phrs.2012.03.012_bib0085","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0304-4165(95)00131-X","article-title":"4-Chloro-m-cresol, a potent and specific activator of the skeletal muscle ryanodine receptor","volume":"1289","author":"Herrmann-Frank","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.phrs.2012.03.012_bib0090","doi-asserted-by":"crossref","first-page":"4815","DOI":"10.1113\/jphysiol.2008.160481","article-title":"Differential dependence of store-operated and excitation-coupled Ca2+ entry in skeletal muscle on STIM1 and Orai1","volume":"586","author":"Lyfenko","year":"2008","journal-title":"J Physiol"},{"key":"10.1016\/j.phrs.2012.03.012_bib0095","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/hh2201.100315","article-title":"Store-operated channels mediate Ca2+ influx and contraction in rat pulmonary artery","volume":"89","author":"Ng","year":"2001","journal-title":"Circ Res"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812000552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661812000552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:52:01Z","timestamp":1760910721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661812000552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1043661812000552"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2012.03.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3,5-Di-t-butyl catechol is a potent human ryanodine receptor 1 activator, not suitable for the diagnosis of malignant hyperthermia susceptibility","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2012.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}